aluminum sulfate has been researched along with Lyme Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, W; Bézay, N; Dubischar, K; Eder-Lingelbach, S; Hochreiter, R; Kadlecek, V; Klingler, A; Larcher-Senn, J; Leroux-Roels, G; Leroux-Roels, I; Wressnigg, N | 1 |
| Aichinger, G; Aschoff, R; Barrett, PN; Crowe, BA; Dvorak, T; Esen, M; Jelinek, T; Kollaritsch, H; Kremsner, PG; Livey, I; Naudts, IF; O'Rourke, M; Pöllabauer, EM; Portsmouth, D; Schmitt, B; Schwendinger, MG; Weisser, R; Wressnigg, N; Zeitlinger, M | 1 |
2 trial(s) available for aluminum sulfate and Lyme Disease
| Article | Year |
|---|---|
Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Adult; Antibodies, Viral; Bacterial Vaccines; Double-Blind Method; Humans; Immunogenicity, Vaccine; Lyme Disease; Myalgia | 2023 |
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alum Compounds; Antibodies, Bacterial; Antigens, Surface; Bacterial Outer Membrane Proteins; Bacterial Vaccines; Borrelia burgdorferi Group; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins; Lyme Disease; Male; Middle Aged; Vaccination; Young Adult | 2014 |